Skip to main content

Table 2 Surgical details

From: Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: Long-term results of a randomized controlled trial

 

Total

CS group

S group

 
 

(N = 169)

(N = 85)

(N = 84)

P-value

Surgery done

      

0,083

   Yes

158

(93%)

76

(90%)

82

(98%)

 

   No

9

(5%)

7

(8%)

2

(2%)

 

   Not recorded

2

(2%)

2

(2%)

0

  

Reason no surgery undertaken

       

   Died before surgery

3

(2%)

1

(1%)

2

(2%)

 

   Progressive disease

       

Tumor unresectable

3

(2%)

3

(4%)

0

  

Distant metastases

3

(2%)

3

(4%)

0

  

Type of resection*

      

0,38

   Transhiatal

113

(71%)

55

(72%)

58

(71%)

 

   Transthoracic

20

(13%)

9

(12%)

11

(13%)

 

   Type not recorded

5

(3%)

4

(5%)

1

(1%)

 

   Other

1

(1%)

1

(1%)

0

  

   No resection performed

19

(12%)

7

(10%)

12

(15%)

 

Postoperative deaths (within 30 days)*

7

(4%)

4

(5%)

3

(4%)

0,62

Non-fatal postoperative complications*

      

0,64

   None

68

(43%)

30

(40%)

38

(46%)

 

   Any

67

(42%)

33

(43%)

34

(41%)

 

   Not recorded

16

(10%)

9

(12%)

7

(9%)

 

Type of non-fatal postoperative complications*, †

     

   Pulmonary

25

(16%)

17

(23%)

8

(10%)

0,048

   Cardiac

6

(4%)

3

(4%)

3

(4%)

1,0

   Anastomotic

       

Subclinical

10

(6%)

5

(7%)

5

(6%)

1,0

Clinical

7

(4%)

3

(4%)

4

(5%)

1,0

   Chylothorax

7

(4%)

4

(5%)

3

(4%)

0,70

   Bleeding

5

(3%)

3

(4%)

2

(2%)

0,67

   Vocal-cord injury

22

(14%)

10

(13%)

12

(15%)

0,82

   Other

10

(6%)

4

(5%)

6

(7%)

0,75

  1. Abbreviations: CS, Chemotherapy followed by surgery; S, Surgery alone
  2. * Percentages based on total patients undergoing surgery.
  3. † Nonfatal postoperative events; comparisons were made by the Fisher's exact test